par Arif, Sefina;Moore, Fabrice ;Marks, Katherine;Bouckenooghe, Thomas ;Dayan, Colin M;Planas, Raquel;Vives-Pi, Marta;Powrie, Jake;Tree, Timothy;Marchetti, Piero;Huang, Guo Cai;Gurzov, Esteban Nicolas ;Pujol-Borrell, Ricardo;Eizirik, Decio L. ;Peakman, Mark
Référence Diabetes (New York, N.Y.), 60, 8, page (2112-2119)
Publication Publié, 2011
Référence Diabetes (New York, N.Y.), 60, 8, page (2112-2119)
Publication Publié, 2011
Article révisé par les pairs
Résumé : | CD4 T-cells secreting interleukin (IL)-17 are implicated in several human autoimmune diseases, but their role in type 1 diabetes has not been defined. To address the relevance of such cells, we examined IL-17 secretion in response to β-cell autoantigens, IL-17A gene expression in islets, and the potential functional consequences of IL-17 release for β-cells. |